These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28111271)

  • 1. Association between glycemic variability and major adverse cardiovascular and cerebrovascular events (MACCE) in patients with acute coronary syndrome during 30-day follow-up.
    Xia J; Xu J; Li B; Liu Z; Hao H; Yin C; Xu D
    Clin Chim Acta; 2017 Mar; 466():162-166. PubMed ID: 28111271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome.
    Takahashi H; Iwahashi N; Kirigaya J; Kataoka S; Minamimoto Y; Gohbara M; Abe T; Okada K; Matsuzawa Y; Konishi M; Maejima N; Hibi K; Kosuge M; Ebina T; Tamura K; Kimura K
    Cardiovasc Diabetol; 2018 Aug; 17(1):116. PubMed ID: 30121076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of glycemic variability on the occurrence of periprocedural myocardial infarction and major adverse cardiovascular events (MACE) after coronary intervention in patients with stable angina pectoris at 6months follow-up.
    Xia J; Xu J; Hu S; Hao H; Yin C; Xu D
    Clin Chim Acta; 2017 Aug; 471():196-200. PubMed ID: 28624498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglyceride-Glucose Index Predicts Major Adverse Cardiovascular and Cerebrovascular Events in Patients with Atrial Fibrillation.
    Yin C; Hou Q; Qi Q; Han Q; Wang X; Wu S; Li K
    Int Heart J; 2024 May; 65(3):373-379. PubMed ID: 38749753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.
    Ikeda N; Hara H; Hiroi Y; Nakamura M
    Atherosclerosis; 2016 Oct; 253():1-6. PubMed ID: 27569457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.
    Patti G; Chello M; Candura D; Pasceri V; D'Ambrosio A; Covino E; Di Sciascio G
    Circulation; 2006 Oct; 114(14):1455-61. PubMed ID: 17000910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between glucose fluctuation from self-monitored blood glucose and the major adverse cardiac events in diabetic patients with acute coronary syndrome during a 6-month follow-up by WeChat application.
    Xia J; Hu S; Xu J; Hao H; Yin C; Xu D
    Clin Chem Lab Med; 2018 Nov; 56(12):2119-2124. PubMed ID: 30016270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of the metabolic syndrome on atrial fibrillation occurrence and outcome after coronary bypass surgery: a 3-year follow-up study.
    Ivanovic B; Tadic M; Bradic Z; Zivkovic N; Stanisavljevic D; Celic V
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):561-8. PubMed ID: 24752869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in white blood cell count is associated with the development of atrial fibrillation after an acute coronary syndrome.
    Tran HV; Erskine NA; Nguyen HL; McManus DD; Awad HH; Kiefe CI; Goldberg RJ
    Int J Cardiol; 2019 Jan; 274():138-143. PubMed ID: 29936044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of atrial fibrillation in patients--survivors of acute coronary syndrome].
    Donetskaia OP; Evdokimova MA; Osmolovskaia VS; Reznichenko NE; Krasil'nikova ES; Dankovtseva EN; Selezneva ND; Glezer MG; Tereshchenko SN; Sidorenko BA; Zateĭshchikov DA
    Kardiologiia; 2009; 49(1):19-24. PubMed ID: 19166396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes.
    Lopes RD; White JA; Atar D; Keltai M; Kleiman NS; White HD; Widimsky P; Zeymer U; Giugliano RP; Tricoci P; Braunwald E; Bode C; Ohman EM; Armstrong PW; Newby LK
    Int J Cardiol; 2013 Oct; 168(3):2510-7. PubMed ID: 23578889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of prevalent and incident atrial fibrillation among patients hospitalized with acute coronary syndrome: findings from the Gulf RACE-2 Registry.
    Hersi A; Alhabib KF; Alsheikh-Ali AA; Sulaiman K; Alfaleh HF; Alsaif S; Al-Mahmeed W; Asaad N; Haitham A; Al-Motarreb A; Suwaidi J; Shehab A
    Angiology; 2012 Aug; 63(6):466-71. PubMed ID: 22144666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of rotational atherectomy in patients with heavy calcified coronary artery lesions: a single-centre experience.
    Bartuś S; Januszek R; Legutko J; Rzeszutko Ł; Dziewierz A; Dudek D
    Kardiol Pol; 2017; 75(6):564-572. PubMed ID: 28631258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma CX3CL1 levels and long term outcomes of patients with atrial fibrillation: the West Birmingham Atrial Fibrillation Project.
    Guo Y; Apostalakis S; Blann AD; Lip GY
    Cerebrovasc Dis; 2014; 38(3):204-11. PubMed ID: 25301077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gender and race on outcomes in dialysis-dependent patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Am J Cardiol; 2011 May; 107(9):1319-23. PubMed ID: 21349486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial.
    Mrdovic I; Savic L; Krljanac G; Perunicic J; Asanin M; Lasica R; Antonijevic N; Kocev N; Marinkovic J; Vasiljevic Z; Ostojic M
    Coron Artery Dis; 2012 Jan; 23(1):1-8. PubMed ID: 22107800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter observational study on the management of hyperglycemia in patients with acute coronary syndrome.
    Avanzini F; Mafrici A; Riva E; Franzosi MG; Milani V; Giudici V; Marelli G; Mariani G; Piatti PM; Roncaglioni MC;
    Nutr Metab Cardiovasc Dis; 2015 Oct; 25(10):916-23. PubMed ID: 26298425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of acute hyperglycaemia on the in-hospital and long-term prognosis in patients with an acute coronary syndrome--a pilot study.
    Bryniarski L; Terlecki M; Bednarek A; Kocowska M; Szynal S; Kawecka-Jaszcz K
    Kardiol Pol; 2011; 69(8):774-81. PubMed ID: 21850617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
    Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.